Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
Naradja Wissmar, Former Administrator at Karolinska Institute, shared on LinkedIn:
”University of Milan teams found SARS-CoV-2 exposure raised blood IL 32, an inflammatory cytokine, and levels stayed high at least 1 year after severe COVID 19, hinting at lingering immune activation and a biomarker for long term effects.”
Title: Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
Authors: Lorenzo Miano, Elena Sinopoli, Alessandro Cherubini, Chiara Suffritti, Serena Pelusi, Fatima Rahmeh, Giuseppe Enzo Lamorte, Flora Peyvandi, Francesco Blasi, Giacomo Grasselli, Alessandra Bandera, Roberta Gualtierotti, Daniele Prati, Luca Vittorio Carlo Valenti
Read the Full Article on Frontiers
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids